West Pharmaceutical Services (STU:WPS) Beta: 0.0407 (As of Jun. 26, 2026)


STU:WPS West Pharmaceutical Services Inc STU:WPS
87 GF Score
Price €305.30
GF Value €318.57
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is West Pharmaceutical Services Beta?

West Pharmaceutical Services STU:WPS +1.43% 87 Beta is 0.0407 as of Jun. 26, 2026. GuruFocus rates STU:WPS with a GF Score™ of 87/100 and a GF Value™ of €318.57 (Fairly Valued). The stock has 9 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), West Pharmaceutical Services's Beta is 0.0407.


West Pharmaceutical Services  (STU:WPS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


West Pharmaceutical Services Beta Related Terms


West Pharmaceutical Services Beta Historical Data

* Premium members only.

The historical data trend for West Pharmaceutical Services's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services Beta Chart

West Pharmaceutical Services Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.50 0.88 -0.13 0.31

West Pharmaceutical Services Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.30 -0.12 0.31 -0.19

STU:WPS vs RMD, MDLN, SOLV: Beta Comparison

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Beta distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Beta falls into.


STU:WPS
87GF Score
West Pharmaceutical Services Inc STU:WPS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

West Pharmaceutical Services Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0407 mean?
West Pharmaceutical Services (STU:WPS) has a Beta of 0.0407 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for West Pharmaceutical Services and its competitors.
Is West Pharmaceutical Services' Beta too high?
West Pharmaceutical Services' current Beta is 0.0407. Overall, West Pharmaceutical Services has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' Beta compare to RMD and MDLN?
West Pharmaceutical Services' Beta of 0.0407 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for West Pharmaceutical Services and its competitors. West Pharmaceutical Services's current Beta is 0.0407. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
Based on GuruFocus' analysis, West Pharmaceutical Services (STU:WPS) is currently considered Fairly Valued. The stock's GF Value™ is €318.57, compared to a current price of €305.30 — trading 4.2% below its estimated fair value. The current Beta is 0.0407. West Pharmaceutical Services' overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For West Pharmaceutical Services (STU:WPS), the current Beta is 0.0407 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is West Pharmaceutical Services (STU:WPS) Overvalued in 2026?

Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued. The current stock price of €305.30 is trading 4.2% below its estimated GF Value™ of €318.57. GuruFocus considers West Pharmaceutical Services to be Fairly Valued.

Key valuation signals for STU:WPS:

  • Beta: 0.0407
  • GF Value™: €318.57 vs. price of €305.30 (4.2% below fair value)
  • GF Score™: 87/100 with 9 warning signs

No single metric tells the full story. See the STU:WPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


West Pharmaceutical Services Business Description

Address 530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
87GF Score

Get the complete analysis for STU:WPS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€305.30
Price
€318.57
GF Value